PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'State Key Laboratory of Medicinal Chemical Biology and College of Pharmacy, Nankai University, Tianjin, China.\', \'Harbour Biomed (Suzhou) Co. Ltd., Suzhou Industrial Park, Suzhou, China.\', \'College of Life Science, Nankai University, Tianjin, China.\', \'Center for Biosafety Mega-Science, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, Hubei, China.\', \'Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.\', \'State Key Laboratory of Virology and National Virus Resource Center, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, Hubei, China.\', \'Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University, Shanghai, China.\', \'Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences, Shanghai Medical College, Fudan University, Shanghai, China.\', \'Frontiers Science Center for Cell Responses, Nankai University, Tianjin, China.\', \'Shanghai Synchrotron Radiation Facility, Shanghai Advanced Research Institute, Chinese Academy of Sciences, Shanghai, China.\', \'MOE Key Laboratory of Protein Science & Collaborative Innovation Center of Biotherapy, School of Medicine, Tsinghua University, Beijing, China.\', \'Guangzhou Laboratory, Guangzhou International Bio-Island, Guangzhou, Guangdong, China.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1371/journal.pbio.3001209
?:doi
?:hasPublicationType
?:journal
  • PLoS biology
is ?:pmid of
?:pmid
?:pmid
  • 33961621
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 4.941
?:rankingScore_hIndex
  • 214
?:title
  • Structural basis for SARS-CoV-2 neutralizing antibodies with novel binding epitopes.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all